Ambry Genetics®, as part of Konica Minolta Precision Medicine, excels at translating scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind the genetic disease.
Fujifilm uses a wealth of experience to enable high-precision and high-resolution mammography.
A personalized approach to breast care. Every woman deserves breast care customized to her personal risk factors. GE Healthcare’s personalized breast care portfolio provides clinicians the tools to provide advanced, personalized care to help achieve the best outcomes.
Invitae is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae’s goal is to aggregate the world’s genetic tests into a single service with higher quality, faster turnaround time and lower prices.
Mammography Educators is an industry-leading provider of training, consultation, and education in breast imaging. They provide training to health care providers at all levels, from students seeking mammography certification to top tier hospitals looking to ensure they are delivering the highest quality images possible to their patients.
MeVis Medical Solutions AG
Veolity™ is a dedicated software package for lung cancer diagnostics optimized for low dose CT lung cancer screening. Veolity includes automated AI-enabled nodule detection, automatic segmentation, temporal comparison, and optimized workflow for structured reporting. Veolity is manufactured by MeVis Medical Solutions AG.
Myriad Genetics is a leading molecular diagnostic company dedicated to saving and improving lives by discovering and delivering tests across major diseases.
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier, more targeted interventions that help lead to longer, healthier lives.
Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes. We do this by delivering the most advanced, radiomics and AI-enabled, lung cancer decision support software, driving the optimal clinical pathway for each patient.
ScreenPoint Medical is the leading developer of AI-driven image analysis technology which enables the automated reading of mammograms and digital breast tomosynthesis examinations. With proven accuracy at least matching that of experienced radiologists, ScreenPoint’s Transpara™ system is the most advanced available, exploiting big data, deep learning and the latest advances in artificial intelligence. The system can identify high-risk breast lesions quickly, enabling earlier detection, earlier treatment and a greater chance of survival.
You might be interested in...
27 Jun 2023
Volpara is Microsoft’s 2023 Healthcare & Life Sciences Partner of the Year
10 Mar 2023
FDA Breast Density Reporting Rule is a Critical Step for Women says Volpara Health, the Leader in AI-assisted Breast Density Measurement
1 May 2023
Volpara announces expanded sponsorship of DenseBreast-Info.org at SBI 2023